Renee Kahl

30%
Flag icon
The patent that was granted to Doudna and Charpentier was for the use of CRISPR-Cas9 in all organisms, from bacteria to humans.
The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race
Rate this book
Clear rating
Open Preview